IDH1 and central nervous system cancer: For example, d-2-hydroxyglutarate–producing (D2HG-producing) mutations in isocitrate dehydrogenase (IDH) were identified in sequencing efforts of gliomas and acute myeloid leukemia (AML) (5, 6).